INFECTIOUS DISEASE SCREENING IN PREGNANCY: ASSESSING SEROPREVALENCE OF HCV, HBV, HIV, SYPHILIS, AND RUBELLA IN KARACHI, PAKISTAN

Authors

  • Dr. Amtul Quddos Latif
  • Dr. Humera Shahzad
  • Dr. Kauser Saldera
  • Dr. Shazia Bhutto
  • Dr. Naeema Asghar Memon
  • Dr. Erum Amir

DOI:

https://doi.org/10.53555/vy1da782

Keywords:

Hepatitis B, Hepatitis C, HIV, Rubella, Syphilis, Pregnancy, Seroprevalence

Abstract

Background: The vertical transmission of hepatitis B virus (HBV), hepatitis C virus (HCV), human immunodeficiency virus (HIV), rubella, and syphilis poses significant public health concerns. This study aimed to investigate the seroprevalence of these infections among pregnant women.

Methodology: This cross-sectional study was conducted on pregnant women who visited the Clinical Pathology Laboratory at Jinnah Postgraduate Medical Centre (JPMC), Karachi, Pakistan, between January and April 2021. Data were collected through a questionnaire assessing demographics and related risk factors. Blood samples were tested for HBsAg, anti-HCV, anti-HIV, rubella, and syphilis using the chemiluminescence enzyme immunoassay method. Data analysis was performed using SPSS version 20.

Results: Out of 560 pregnant women screened, 0.7% tested positive for hepatitis B, 1.6% for HCV, and 100% were negative for HIV and syphilis. Rubella IgG positivity was 85%, with 99% negative for rubella IgM. Ethnic distribution showed 58% Urdu speakers, followed by Pashto (10%) and Sindhi (7.5%). Previous birth history revealed 69% had more than one birth, and 16% reported blood transfusions, with older women having a higher prevalence (p = 0.005). Significant variation in gestational age distribution was observed (p < 0.001).

Conclusion: In conclusion, the seroprevalence of rubella IgG was high, while infections such as HCV, HBV, and rubella IgM were less prevalent among pregnant women, with no cases of HIV or syphilis detected. This highlights the importance of routine prenatal screening for vertical transmission prevention. Effective immunization and treatment strategies are essential to minimize these infections' impact on maternal and neonatal health.

Author Biographies

  • Dr. Amtul Quddos Latif

    Associate Professor Pathology, Main Clinical Pathology Laboratory, Jinnah Postgraduate Medical Center (JPMC), Karachi, Pakistan

     

  • Dr. Humera Shahzad

    Assistant Professor Pathology, Basic Medical Sciences Institute (BMSI), JPMC, JSMU Karachi, Pakistan

  • Dr. Kauser Saldera

    Associate Professor Physiology, Basic Medical Sciences Institute (JPMC), Karachi, Pakistan

     

  • Dr. Shazia Bhutto

    Medical officer, National Institute of Child Health, Karachi, Pakistan

  • Dr. Naeema Asghar Memon

    Assistant Professor Department of Community Medicine Shaheed Muhtarma Benazir Bhutto Medical College, Lyari, Karachi, Pakistan

     

  • Dr. Erum Amir

    Assistant Professor Clinical Pathology, Department of Pathology, Karachi Medical and Dental   College (KMDC), Karachi, Pakistan

References

1. Zeng Y, Chen S, Fu Y, Wu W, Chen T, Chen J, Yang B, Ou Q. Gut microbiota dysbiosis in patients with hepatitis B virus–induced chronic liver disease covering chronic hepatitis, liver cirrhosis and hepatocellular carcinoma. Journal of viral hepatitis. 2020 Feb;27(2):143-55.

2. Tsukuda, S., & Watashi, K. (2020). Hepatitis B virus biology and life cycle. Antiviral research, 182, 104925.

3. Chang MH. Prevention of hepatitis B virus infection and liver cancer. Viruses and Human Cancer: From Basic Science to Clinical Prevention. 2021:71-90.

4. Tüfekci, S., Aygün, E., & Halis, H. (2021). Evaluation of immunogenicity after first dose of hepatitis B vaccine in newborns with very low birth weight. Human Vaccines & Immunotherapeutics, 17(12), 5590-5594.

5. Jing W, Liu J, Liu M. Eliminating mother-to-child transmission of HBV: progress and challenges in China. Frontiers of Medicine. 2020 Feb; 14:21-9.

6. Chappell, C. A., Scarsi, K. K., Kirby, B. J., Suri, V., Gaggar, A., Bogen, D. L., ... & Hillier, S. L. (2020). Ledipasvir plus sofosbuvir in pregnant women with hepatitis C virus infection: a phase 1 pharmacokinetic study. The Lancet Microbe, 1(5), e200-e208.

7. Wang X, Wang Q, Wang C, Zhang T, Li Z, Ma Z, Wang A. Prevention of mother-to-child transmission of HIV—China, 2011–2020. China CDC Weekly. 2021 Nov 11;3(48):1018.

8. Ragusa, R., Corsaro, L. S., Frazzetto, E., Bertino, E., Bellia, M. A., & Bertino, G. (2020). Hepatitis C virus infection in children and pregnant women: an updated review of the literature on screening and treatments. American Journal of Perinatology Reports, 10(01), e121-e127.

9. Altınbas, S., Holmes, J. A., & Altınbas, A. (2020). Hepatitis C virus infection in pregnancy: an update. Gastroenterology Nursing, 43(1), 12-21

10. Kushner, T., & Reau, N. (2021). Changing epidemiology, implications, and recommendations for hepatitis C in women of childbearing age and during pregnancy. Journal of Hepatology, 74(3), 734-741.

11. Mehmood S, Raza H, Abid F, Saeed N, Rehman HM, Javed S, Khan MS. National prevalence rate of hepatitis B and C in Pakistan and its risk factors. Journal of Public Health. 2020 Dec; 28:751-64.

12. Krist AH, Davidson KW, Mangione CM, Barry MJ, Cabana M, Caughey AB, Donahue K, Doubeni CA, Epling JW, Kubik M, Ogedegbe G. Screening for hepatitis B virus infection in adolescents and adults: US Preventive Services Task Force recommendation statement. Jama. 2020 Dec 15;324(23):2415-22.

13. Chilaka, V. N., & Konje, J. C. (2021). Viral Hepatitis in pregnancy. European Journal of Obstetrics & Gynecology and Reproductive Biology, 256, 287-296.

14. Shahapur PR, Kandi V. Seroprevalence of Rubella virus-specific antibodies in women and the diagnostic efficacy of enzyme-linked immunoassay and rapid immunochromatographic tests. Cureus. 2020 Mar;12(3).

15. Malik MA, Rohm LR, van Baal P, van Doorslaer EV. Improving maternal and child health in Pakistan: a programme evaluation using a difference in difference analysis. BMJ global health. 2021 Dec 1;6(12): e006453.

Downloads

Published

2024-06-16

How to Cite

Dr. Amtul Quddos Latif, Dr. Humera Shahzad, Dr. Kauser Saldera, Dr. Shazia Bhutto, Dr. Naeema Asghar Memon, & Dr. Erum Amir. (2024). INFECTIOUS DISEASE SCREENING IN PREGNANCY: ASSESSING SEROPREVALENCE OF HCV, HBV, HIV, SYPHILIS, AND RUBELLA IN KARACHI, PAKISTAN. Journal of Population Therapeutics and Clinical Pharmacology, 29(02), 591-600. https://doi.org/10.53555/vy1da782
More Citation Formats

Issue

Section

Articles

How to Cite

Dr. Amtul Quddos Latif, Dr. Humera Shahzad, Dr. Kauser Saldera, Dr. Shazia Bhutto, Dr. Naeema Asghar Memon, & Dr. Erum Amir. (2024). INFECTIOUS DISEASE SCREENING IN PREGNANCY: ASSESSING SEROPREVALENCE OF HCV, HBV, HIV, SYPHILIS, AND RUBELLA IN KARACHI, PAKISTAN. Journal of Population Therapeutics and Clinical Pharmacology, 29(02), 591-600. https://doi.org/10.53555/vy1da782

Most read articles by the same author(s)